U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry EPIMERIC
Molecular Formula C19H22O2.C7H17NO5
Molecular Weight 477.5904
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of VEDAPROFEN MEGLUMINE

SMILES

CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CC(C(O)=O)C1=CC=C(C2CCCCC2)C3=C1C=CC=C3

InChI

InChIKey=SGAJMCQBAWHKKC-WZTVWXICSA-N
InChI=1S/C19H22O2.C7H17NO5/c1-13(19(20)21)15-11-12-16(14-7-3-2-4-8-14)18-10-6-5-9-17(15)18;1-8-2-4(10)6(12)7(13)5(11)3-9/h5-6,9-14H,2-4,7-8H2,1H3,(H,20,21);4-13H,2-3H2,1H3/t;4-,5+,6+,7+/m.0/s1

HIDE SMILES / InChI
Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: O19183
Gene ID: 791253.0
Gene Symbol: PTGS2
Target Organism: Equus caballus (Horse)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
QUADRISOL

Approved Use

Reduction of inflammation and relief of pain associated with musculo-skeletal disorders and soft tissue lesions (traumatic injuries and surgical trauma).

Launch Date

1997
PubMed

PubMed

TitleDatePubMed
Comparison of vedaprofen and meloxicam in dogs with musculoskeletal pain and inflammation.
2002 May
The pharmacokinetics of vedaprofen and its enantiomers in dogs after single and multiple dosing.
2005 Jun
Influence of vedaprofen (Quadrisol) on quality and freezability of stallion semen.
2005 Nov
Vedaprofen therapy in cats with upper respiratory tract infection or following ovariohysterectomy.
2007 Feb
Comparison of the effects of firocoxib, carprofen and vedaprofen in a sodium urate crystal induced synovitis model of arthritis in dogs.
2008 Feb
Analgesic efficacy of perioperative use of vedaprofen, tramadol or their combination in cats undergoing ovariohysterectomy.
2009 Jun
Perioperative administration of vedaprofen, tramadol or their combination does not interfere with platelet aggregation, bleeding time and biochemical variables in cats.
2009 Jun
Treatment of persistent mating-induced endometritis in mares with the non-steroid anti-inflammatory drug vedaprofen.
2010 Dec
Practical experience with the treatment of recipient mares with a non-steroidal anti-inflammatory drug in an equine embryo transfer programme.
2010 Dec

Sample Use Guides

Twice daily administration. An initial dose of 2 mg/kg (2.0 ml/100 kg) is followed by a maintenance dose of 1 mg/kg (1.0 ml/100 kg) given every 12 hours. Treatment can be continued for a maximum of 14 consecutive days.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Name Type Language
VEDAPROFEN MEGLUMINE
Common Name English
1-NAPHTHALENEACETIC ACID, 4-CYCLOHEXYL-.ALPHA.-METHYL-, COMPD. WITH D-1-DEOXY-1-(METHYLAMINO)GLUCITOL
Common Name English
Code System Code Type Description
SMS_ID
300000023674
Created by admin on Fri Dec 15 16:59:23 GMT 2023 , Edited by admin on Fri Dec 15 16:59:23 GMT 2023
PRIMARY
FDA UNII
S154JX9N3H
Created by admin on Fri Dec 15 16:59:23 GMT 2023 , Edited by admin on Fri Dec 15 16:59:23 GMT 2023
PRIMARY
PUBCHEM
139033180
Created by admin on Fri Dec 15 16:59:23 GMT 2023 , Edited by admin on Fri Dec 15 16:59:23 GMT 2023
PRIMARY